https://www.selleckchem.com/pr....oducts/semaglutide.h
rly all treatment episodes with lorazepam (88.9 %) or midazolam (97.8 %) the dosage was below the recommended level. Missing the SE in the prehospital setting was frequent and associated with a higher risk of developing a new neurological deficit. Treatment with BZD was associated with a lower risk of developing a new neurological deficit, but was underdosed in the vast majority of situations. Missing the SE in the prehospital setting was frequent and associated with a higher risk of developing a new neurological deficit. Treatment